Department of
Researchers at WashU Medicine have identified a gene that may help explain why some individuals are more likely than others to develop opioid addiction. The study builds on human genetic studies suggesting that the gene CNIH3 may influence how opioid use begins and develops over time.
A study by WashU Medicine researchers offers new insight into how environmental factors protect against opioid addiction and support recovery.
Robert W. Gereau IV, PhD, the Dr. Seymour and Rose T. Brown Professor and vice chair for research in the Department of Anesthesiology at WashU Medicine, received the Ray Dingledine Award for Research Impact on March 6, 2026.
Sarah Bernhard, PhD, and Susovan Chowdhury, PhD, co-led a study showing how the delta opioid receptor could be targeted to develop safer, more effective pain treatments.
The Department of Anesthesiology is pleased to announce the appointment of Dr. Meaghan Creed as Associate Division Chief of Basic Research for the WashU Medicine Pain Center, effective March 1, 2026.
The department is pleased to announce the appointment of Dr. Wayland Cheng as the Associate Division Chief of the Division of Basic Research (DBR), effective March 1, 2026.
Researchers, including Dr. Elgendy, developed a gut-restricted experimental drug that, in mice, improves nutrient absorption and protects the liver from damage after small bowel resection.
For the second consecutive year, the department leads the nation in NIH funding, earning $30.6 million to support 164 research projects and more than $37 million in total research awards.
Padma Gulur, MD, nationally renowned pain specialist, will lead the Department of Anesthesiology at WashU Medicine beginning Aug. 1.
WashU Medicine researchers, including Dr. Jordan McCall from the Department of Anesthesiology, have shown that certain psychedelic compounds break the link between neurological functions and blood flow in the brain.